GL1X · GenesisL1 explorer

MolNFT v1 · #183761 · protein

X-ray structure of SMYD3 in complex with benzodiazepine-type inhibitor compound 15

7O2A · Histone-lysine N-methyltransferase SMYD3: “X-ray structure of SMYD3 in complex with benzodiazepine-type inhibitor compound 15”. X-ray diffraction, 3 ligands (UZT, SAM, ZN), 5 pockets (best druggability 0.79). MolNFT v1 #183761 on…

PDB
7O2A
Type
protein
Length
427 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase SMYD3
EC
2.1.1.354
UniProt
Q9H7B4
Ligands
UZT, SAM, ZN
Pockets
5 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354)protein42752% helix, 13% strandQ9H7B4

Ligands and binding sites

  • UZT · (2S)-1-(4-azanylpiperidin-1-yl)carbonyl-N-(2-cyclopropylethyl)-2-methyl-4-oxidanylidene-3,5-dihydro-2H-1,5-benzodiazepine-7-carboxamide · ligand · chains A
  • SAM · S-adenosylmethionine · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110180.790.8178UZT
21520.580.8325SAM
31660.540.7934empty
4980.450.8025empty
5520.250.7313empty

Compared structures

  • 7O2A · X-RAY STRUCTURE OF SMYD3 IN COMPLEX WITH benzodiazepine-type inhibitor compound 15 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H7B4 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase SMYD3 (Q9H7B4) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.